Profiling intra-patient type I diabetes behaviors
Iván Contreras1, Carmen Quirós2, Marga Giménez2
1Institut d'Informática i Aplicacions, Universitat de Girona, Campus de Montilivi, Girona, Spain.
Computer Methods and Programs in Biomedicine
|October 1, 2016
Summary
A new method identifies blood glucose dynamics profiles in type 1 diabetes patients, improving personalized insulin therapy. This tool helps manage daily variations for better diabetes control.
Area of Science:
- Biomedical Engineering
- Computational Biology
- Endocrinology
Background:
- Type 1 diabetes presents significant intra-patient variability in blood glucose levels, challenging effective glycemic control.
- Tailored therapies are needed to address diverse patient conditions and daily situations like exercise, weekends, and menstruation.
Purpose of the Study:
- To develop and validate a novel methodology for identifying distinct blood glucose dynamics profiles in type 1 diabetic patients.
- To enable more accurate and personalized diabetes management strategies.
Main Methods:
- A clustering methodology based on normalized compression distance was employed.
- The approach was validated using simulated (in silico) data from 10 patients across different exercise scenarios.
- Real-world (in vivo) experiments with 10 patients assessed the methodology's effectiveness in practical settings.
Main Results:
- In silico validation demonstrated the methodology's ability to differentiate between well-controlled and poorly controlled exercise days.
- In vivo experiments revealed distinct blood glucose profiles for various daily situations (e.g., working days, holidays), indicating different insulin needs.
Conclusions:
- A blood glucose profiling tool can be rapidly integrated into existing Continuous Glucose Monitoring (CGM) and Continuous Subcutaneous Insulin Infusion (CSII) systems.
- This tool will aid physicians in refining insulin therapy and empower patients with improved self-management capabilities for type 1 diabetes.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
5.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.8K
Diabetes Mellitus: Type 2 and Gestational
5.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.3K
Diabetes: Symptoms, Diagnosis, and Complications
2.6K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.6K
Diabetes: Management and Pharmacotherapy
1.2K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.2K
Carbohydrate Metabolism
14.8K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
14.8K
Pathophysiology of Diabetes
4.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.1K


